Marella Thorell - Feb 7, 2025 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
EVP and Chief Financial Officer
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact for Marella Thorell
Stock symbol
MCRB
Transactions as of
Feb 7, 2025
Transactions value $
$0
Form type
4
Date filed
2/11/2025, 04:15 PM
Previous filing
Jul 1, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (Right to Buy) Award $0 +650K $0.00 650K Feb 7, 2025 Common Stock 650K $0.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on February 7, 2026. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Remarks:

EVP and Chief Financial Officer